• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
CONCLUSIONS: SLC7A9 influences the malignant behavior of ESCC cells. Tumor SLC7A9 expression may serve as a novel biomarker for predicting lymph node metastasis and recurrence in ESCC patients.PMID:34773193 | DOI:10.1245/s10434-021-11001-1
Source: Ann Oncol - November 13, 2021 Category: Cancer & Oncology Authors: Hayato Baba Mitsuro Kanda Koichi Sawaki Shunsuke Nakamura Sei Ueda Dai Shimizu Masahiko Koike Yasuhiro Kodera Tsutomu Fujii Source Type: research

Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma.
CONCLUSIONS: B4GALNT4 influences the malignant behavior of ESCC cells. B4GALNT4 expression may serve as a novel prognostic marker, independent of established risk factors, for ESCC patients. PMID: 32253672 [PubMed - as supplied by publisher]
Source: Ann Oncol - April 5, 2020 Category: Cancer & Oncology Authors: Baba H, Kanda M, Sato Y, Sawaki K, Shimizu D, Koike M, Motoyama S, Kodera Y, Fujii T Tags: Ann Surg Oncol Source Type: research

Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
CONCLUSIONS: The results suggest that BST-2 is involved in tumor progression and serves as an independent prognostic classifier for patients with GC. Because BST-2 is expressed on the cell membrane, BST-2 could be a therapeutic target for GC, CRC, and ESCC. PMID: 26832883 [PubMed - as supplied by publisher]
Source: Ann Oncol - February 1, 2016 Category: Cancer & Oncology Authors: Mukai S, Oue N, Oshima T, Mukai R, Tatsumoto Y, Sakamoto N, Sentani K, Tanabe K, Egi H, Hinoi T, Ohdan H, Yasui W Tags: Ann Surg Oncol Source Type: research